Clinical Effect of Quyou Prescription in the Treatment of Persistent High-risk HPV Infection

Fujian Provincial Maternity and Children's Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) meet one of the three conditions:?tested positive for HPV16/18 and pathological tissue result of LSIL or below,cervical colposcopy biopsy of LSIL or below,and LSIL lesions less than two years;?tested negative for HPV16 or 18,but positive for other types of high-risk HPV,cytological evidence of ACUS or above,cervical colposcopy biopsy of LSIL or below,and LSIL lesions less than two years;?tested negative for HPV16 or 18,but positive for other types of high-risk HPV,cytological evidence of NILM;
•(2) homotype HPV infection more than half a year;
•(3) conforming to the standard of TCM syndrome of dampness and heat;
•(4) women aged 25-65 with a history of sexual life and regular menstrual cycles;
•(5) patients with normal liver and kidney function and no history of severe drug allergy;
•(6) gave informed consent volunteering to participate in the study.

•(1) women who were not avoiding pregnancy,were pregnant, or were breastfeeding;
•(2) those who had used other HPV drugs in the first 3 months of enrollment;
•(3) patients participating in clinical trials of other drugs.;
•(4) allergic constitution, such as allergic history of two or more drugs and food,or allergic to the ingredients of a given drug;
•(5) patients with HSIL or above indicated by cervical biopsy under colposcopy.

发起方

Fujian Provincial Maternity and Children's Hospital